Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Guidance Outlining Total Artificial Disc Trial Design Issued

This article was originally published in The Gray Sheet

Executive Summary

Investigational device exemption applications for total artificial disc systems should include plans for product durability testing and multi-center clinical trials with at least two years of follow-up, according to new FDA guidance

You may also be interested in...



Globus Medical Preps IPO, Sales Force Ramp Ahead Of Artificial Cervical Disc Approval

Firm files for initial public stock offering, awaits PMA approval of its Secure-C artificial cervical disc.

Orthofix Set To Accelerate Advent Cervical Disc Trial Enrollment In Early 2009

Orthofix plans to accelerate a clinical study of its Advent artificial cervical disc in early 2009, the firm said during its first investor day Sept. 8 in New York

Orthofix Set To Accelerate Advent Cervical Disc Trial Enrollment In Early 2009

Orthofix plans to accelerate a clinical study of its Advent artificial cervical disc in early 2009, the firm said during its first investor day Sept. 8 in New York

Related Content

UsernamePublicRestriction

Register

OM007016

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel